Applied pharmacogenomics in cardiovascular medicine. Weeke P, Roden DM (2014) Annu Rev Med 65: 81-94 Structural basis of thrombin-mediated factor V activation: the Glu666-Glu672 sequence is critical for processing at the heavy chain-B domain junction. Corral-Rodríguez MÁ, Bock PE, Hernández-Carvajal E, Gutiérrez-Gallego R, Fuentes-Prior P (2011) Blood 117: 7164-73 Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Massion PB, Peters P, Ledoux D, Zimermann V, Canivet JL, Massion PP, Damas P, Gothot A (2012) Intensive Care Med 38: 1326-35 Role of the catalytic serine in the interactions of serine proteinases with protein inhibitors of the serpin family. Contribution of a covalent interaction to the binding energy of serpin-proteinase complexes. Olson ST, Bock PE, Kvassman J, Shore JD, Lawrence DA, Ginsburg D, Björk I (1995) J Biol Chem 270: 30007-17 Inactivation of thrombin by antithrombin is accompanied by inactivation of regulatory exosite I. Bock PE, Olson ST, Björk I (1997) J Biol Chem 272: 19837-45 Kinetic characterization of the proteinase binding defect in a reactive site variant of the serpin, antithrombin. Role of the P1' residue in transition-state stabilization of antithrombin-proteinase complex formation. Olson ST, Stephens AW, Hirs CH, Bock PE, Björk I (1995) J Biol Chem 270: 9717-24 Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor. Björk I, Ylinenjärvi K, Olson ST, Bock PE (1992) J Biol Chem 267: 1976-82 Characterization of a heparin binding site on the heavy chain of factor XI. Zhao M, Abdel-Razek T, Sun MF, Gailani D (1998) J Biol Chem 273: 31153-9 Characterization of a heparin-binding site on the catalytic domain of factor XIa: mechanism of heparin acceleration of factor XIa inhibition by the serpins antithrombin and C1-inhibitor. Yang L, Sun MF, Gailani D, Rezaie AR (2009) Biochemistry 48: 1517-24 Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa. Schmidt AE, Sun MF, Ogawa T, Bajaj SP, Gailani D (2008) Biochemistry 47: 1326-35 Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity. Rezaie AR, Sun MF, Gailani D (2006) Biochemistry 45: 9427-33 Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites. Bedsted T, Swanson R, Chuang YJ, Bock PE, Björk I, Olson ST (2003) Biochemistry 42: 8143-52 Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: application to specific and nonspecific protein-heparin interactions. Olson ST, Bock PE, Sheffer R (1991) Arch Biochem Biophys 286: 533-45 The hyperglycemic byproduct methylglyoxal impairs anticoagulant activity through covalent adduction of antithrombin III. Jacobson R, Mignemi N, Rose K, O'Rear L, Sarilla S, Hamm HE, Barnett JV, Verhamme IM, Schoenecker J (2014) Thromb Res 134: 1350-7 Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay. Hortin GL, Tollefsen DM, Santoro SA (1988) Am J Clin Pathol 89: 515-7 Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome. Sebag SC, Bastarache JA, Ware LB (2011) Curr Pharm Biotechnol 12: 1481-96
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.